Stay updated on CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.

Latest updates to the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, Revision: v3.3.3, was added to the Record History. The HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision entries show v3.3.2 added and v3.2.0 removed; these are minor metadata changes to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the notice about potential data delays due to government funding lapses and links to operating-status updates.SummaryDifference0.7%

- Check51 days agoChange DetectedNew screenshot shows the same record history layout with an added version entry (2025-10-02) reflecting an update to NCT05081492. The overall page structure remains unchanged aside from this administrative update.SummaryDifference0.1%

- Check73 days agoChange DetectedAdds a new date and a new Study Status section with a recent timestamp; removes an older date, shifting temporal context forward.SummaryDifference1%

- Check80 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference13%

Stay in the know with updates to CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CF33-hNIS-antiPDL1 in Metastatic TNBC Clinical Trial page.